Chongqing Daxin Pharmaceutical Co., Ltd. is the largest manufacturing base of Lovastatin in the world with strong pharmaceutical manufacturing capability which owns advanced medical manufacturing equipments and two large-scale pharmaceutical manufacturing bases, including a new base complying with international GMP standards located in Shuitu, Liangjiang New District, Chongqing City. There are about hundred of APIs, finished dosages and intermediates, including cardio-vascular, antibiotics, immunosuppressant, plasma volume expander, and etc.
more >
Year of Establishment:
1941
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
N;
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: